CTCBIO Inc. (KOSDAQ:060590)
South Korea · Delayed Price · Currency is KRW 3,895.00
+105.00 (2.77%)
At close: Apr 1, 2026
CTCBIO Market Cap
CTCBIO has a market cap or net worth of 93.12 billion as of April 1, 2026. Its market cap has decreased by -43.47% in one year.
Market Cap
93.12B
Enterprise Value
118.47B
Revenue
123.77B
Ranking
n/a
PE Ratio
28.40
Stock Price
3,895.00
Market Cap Chart
Since March 3, 2003, CTCBIO's market cap has increased from 10.66B to 93.12B, an increase of 773.88%. That is a compound annual growth rate of 9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 93.12B | -15.78% |
| Dec 30, 2025 | 110.58B | -29.39% |
| Dec 30, 2024 | 156.60B | -38.79% |
| Dec 28, 2023 | 255.82B | 69.84% |
| Dec 29, 2022 | 150.63B | -28.80% |
| Dec 30, 2021 | 211.56B | 32.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 112.45B |
| Quratis | 108.73B |
| NovMetaPharma | 103.25B |
| CHA Vaccine Research Institute | 102.09B |
| TegoScience | 101.60B |
| Cell Biotech | 98.14B |
| Progen | 94.56B |
| Choong Ang Vaccine Laboratory | 85.60B |